Literature DB >> 11093827

Risk factors and age-incidence relationships for contralateral breast cancer.

P Vaittinen1, K Hemminki.   

Abstract

The nation-wide Swedish Family-Cancer Database was used to analyze the risk of contralateral breast cancer among 72,092 women with unilateral breast cancer. Contralateral breast cancer, defined as being diagnosed 6 months or more after the first breast cancer, affected 2,529 women (3.5%). In a young age group the incidence of contralateral breast cancer was 50 times higher than the incidence of first breast cancer; for all contralateral breast cancer the difference was 5-fold. Because only 1 breast was at risk for contralateral breast cancer, the true differences to unilateral cancer were 2 times higher. The age-incidence relationship was unusual, exhibiting a high incidence (800/10(5) person-years) component at an early age (25 to 49 years) and a lower incidence (460/10(5) person-years) component at a later age (50-80 years). The discrete components suggest population heterogeneity. Age at diagnosis of the first breast cancer and family history of breast cancer associated with the risk of contralateral breast cancer. Other, weaker risk factors were birth cohort, age at first childbirth, parity and interval between first and second breast cancer. The incidence of familial contralateral breast cancer was 1. 5 times higher than that of sporadic disease, and its age-incidence curve also exhibited 2 separate components. The age-incidence relationships of contralateral breast cancer suggest that the disease affects a small and heterogeneous susceptible population. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2000        PMID: 11093827     DOI: 10.1002/1097-0215(20001215)88:6<998::aid-ijc25>3.0.co;2-0

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  21 in total

1.  Using lifetime risk estimates to recommend magnetic resonance imaging screening for breast cancer survivors.

Authors:  Rinaa S Punglia; Michael J Hassett
Journal:  J Clin Oncol       Date:  2010-08-09       Impact factor: 44.544

2.  Breast Cancer Family History and Contralateral Breast Cancer Risk in Young Women: An Update From the Women's Environmental Cancer and Radiation Epidemiology Study.

Authors:  Anne S Reiner; Julia Sisti; Esther M John; Charles F Lynch; Jennifer D Brooks; Lene Mellemkjær; John D Boice; Julia A Knight; Patrick Concannon; Marinela Capanu; Marc Tischkowitz; Mark Robson; Xiaolin Liang; Meghan Woods; David V Conti; David Duggan; Roy Shore; Daniel O Stram; Duncan C Thomas; Kathleen E Malone; Leslie Bernstein; Jonine L Bernstein
Journal:  J Clin Oncol       Date:  2018-04-05       Impact factor: 44.544

Review 3.  The increasing use of prophylactic mastectomy in the prevention of breast cancer.

Authors:  Todd M Tuttle; Andrea Abbott; Amanda Arrington; Natasha Rueth
Journal:  Curr Oncol Rep       Date:  2010-01       Impact factor: 5.075

Review 4.  Trends and concepts in post-mastectomy breast reconstruction.

Authors:  Hana Farhangkhoee; Evan Matros; Joseph Disa
Journal:  J Surg Oncol       Date:  2016-02-14       Impact factor: 3.454

5.  Declining incidence of contralateral breast cancer in the United States from 1975 to 2006.

Authors:  Hazel B Nichols; Amy Berrington de González; James V Lacey; Philip S Rosenberg; William F Anderson
Journal:  J Clin Oncol       Date:  2011-03-14       Impact factor: 44.544

6.  High constant incidence rates of second primary cancers of the head and neck: a pooled analysis of 13 cancer registries.

Authors:  Cristina Bosetti; Ghislaine Scelo; Shu-Chun Chuang; Jon M Tonita; Sharon Tamaro; Jon G Jonasson; Erich V Kliewer; Kari Hemminki; Elisabete Weiderpass; Eero Pukkala; Elizabeth Tracey; Jorgen H Olsen; Vera Pompe-Kirn; David H Brewster; Carmen Martos; Kee-Seng Chia; Paul Brennan; Mia Hashibe; Fabio Levi; Carlo La Vecchia; Paolo Boffetta
Journal:  Int J Cancer       Date:  2010-11-09       Impact factor: 7.396

7.  Reproductive factors and risk of contralateral breast cancer by BRCA1 and BRCA2 mutation status: results from the WECARE study.

Authors:  Jenny N Poynter; Bryan Langholz; Joan Largent; Lene Mellemkjaer; Leslie Bernstein; Kathleen E Malone; Charles F Lynch; Ake Borg; Patrick Concannon; Sharon N Teraoka; Shanyan Xue; Anh T Diep; Therese Törngren; Colin B Begg; Marinela Capanu; Robert W Haile; Jonine L Bernstein
Journal:  Cancer Causes Control       Date:  2010-02-04       Impact factor: 2.506

8.  Are synchronous and metachronous bilateral breast cancers different? An immunohistochemical analysis aimed at intrinsic tumor phenotype.

Authors:  Elżbieta Senkus; Jolanta Szade; Beata Pieczyńska; Anna Zaczek; Joanna Pikiel; Katarzyna Sosińska-Mielcarek; Agnieszka Karpińska; Jacek Jassem
Journal:  Int J Clin Exp Pathol       Date:  2013-12-15

Review 9.  Bilateral breast cancers.

Authors:  Steven A Narod
Journal:  Nat Rev Clin Oncol       Date:  2014-02-04       Impact factor: 66.675

10.  Estrogen receptor status in relation to risk of contralateral breast cancer-a population-based cohort study.

Authors:  Maria E C Sandberg; Per Hall; Mikael Hartman; Anna L V Johansson; Sandra Eloranta; Alexander Ploner; Kamila Czene
Journal:  PLoS One       Date:  2012-10-08       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.